AJMC®: How is COPD definitively diagnosed in clinical practice, and how does this disease create a clinical burden on patients and caregivers? Dr Rali: COPD diagnosis requires both clinical context ...
Add Yahoo as a preferred source to see more of our stories on Google. Woman’s World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Sure, ...
Hosted on MSN
FDA approves GSK’s Nucala to treat COPD
GSK has gained approval from the US Food and Drug Administration (FDA) for its monoclonal antibody, Nucala (mepolizumab), as an add-on maintenance treatment for the adult population with chronic ...
FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...
AJMC®: What recent developments in the therapeutic landscape of chronic obstructive pulmonary disease (COPD) do you think have the greatest potential to shift how treatment is managed? Dr Martinez: ...
Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the ...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that obstructs airflow and makes breathing difficult. It encompasses several respiratory conditions, including chronic ...
Oxygen therapy can help people with COPD breathe better and do daily activities with less difficulty. There are three types of oxygen therapy: compressed oxygen cylinders, liquid oxygen, and oxygen ...
About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.
Many people with COPD can control their symptoms by using inhaled medicines each day. But inhaled medicines may not offer enough relief for people who also have high levels of a type of white blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results